Arthur Haney
Concepts (319)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Infertility, Female | 22 | 2004 | 75 | 1.810 |
Why?
| Endometriosis | 22 | 2001 | 53 | 1.600 |
Why?
| Tissue Adhesions | 11 | 2000 | 46 | 1.160 |
Why?
| Uterus | 7 | 2003 | 156 | 1.140 |
Why?
| Polytetrafluoroethylene | 6 | 1997 | 68 | 0.920 |
Why?
| Uterine Neoplasms | 6 | 2003 | 164 | 0.790 |
Why?
| Leiomyoma | 4 | 2003 | 129 | 0.690 |
Why?
| Hysterectomy | 4 | 2007 | 78 | 0.690 |
Why?
| Endometrium | 6 | 2004 | 47 | 0.610 |
Why?
| Ascitic Fluid | 12 | 2002 | 39 | 0.570 |
Why?
| Menotropins | 8 | 1991 | 21 | 0.540 |
Why?
| Embolization, Therapeutic | 3 | 2003 | 179 | 0.530 |
Why?
| Insemination, Artificial | 7 | 1993 | 16 | 0.520 |
Why?
| Postoperative Complications | 9 | 2000 | 2118 | 0.520 |
Why?
| Peritoneum | 3 | 2000 | 43 | 0.500 |
Why?
| Infertility | 6 | 1997 | 36 | 0.500 |
Why?
| Ovulation Induction | 6 | 1997 | 28 | 0.500 |
Why?
| Superovulation | 5 | 1993 | 8 | 0.500 |
Why?
| Ovariectomy | 3 | 2007 | 71 | 0.460 |
Why?
| Peritoneal Cavity | 6 | 1996 | 21 | 0.460 |
Why?
| Cellulose | 3 | 1996 | 57 | 0.460 |
Why?
| Estrogen Replacement Therapy | 2 | 2007 | 48 | 0.450 |
Why?
| Luteinizing Hormone | 7 | 1997 | 155 | 0.430 |
Why?
| Ovary | 6 | 2002 | 222 | 0.430 |
Why?
| Macrophages | 12 | 1994 | 523 | 0.420 |
Why?
| Progesterone | 7 | 1993 | 104 | 0.410 |
Why?
| Female | 73 | 2007 | 41483 | 0.390 |
Why?
| Hormones | 5 | 1993 | 120 | 0.360 |
Why?
| Estradiol | 8 | 2006 | 256 | 0.340 |
Why?
| Macrophages, Peritoneal | 3 | 2002 | 21 | 0.340 |
Why?
| Pregnancy | 15 | 2003 | 2515 | 0.330 |
Why?
| Sperm Motility | 4 | 1995 | 17 | 0.330 |
Why?
| Gonadotropin-Releasing Hormone | 5 | 2000 | 93 | 0.320 |
Why?
| Reproductive Medicine | 1 | 2004 | 7 | 0.320 |
Why?
| Prostheses and Implants | 2 | 1997 | 138 | 0.300 |
Why?
| Ovulation | 6 | 1994 | 42 | 0.290 |
Why?
| Peritoneal Diseases | 2 | 1994 | 16 | 0.290 |
Why?
| Chorionic Gonadotropin | 6 | 1997 | 68 | 0.290 |
Why?
| Abortion, Habitual | 1 | 2003 | 39 | 0.280 |
Why?
| Fertilization in Vitro | 6 | 1991 | 51 | 0.270 |
Why?
| Cellulose, Oxidized | 2 | 1992 | 4 | 0.260 |
Why?
| Granulosa Cells | 4 | 1990 | 25 | 0.260 |
Why?
| Peritonitis | 2 | 1994 | 34 | 0.250 |
Why?
| Humans | 66 | 2007 | 75301 | 0.240 |
Why?
| Neoplasms, Hormone-Dependent | 1 | 2000 | 40 | 0.230 |
Why?
| Medroxyprogesterone | 2 | 1991 | 8 | 0.230 |
Why?
| Uterine Diseases | 3 | 1997 | 21 | 0.230 |
Why?
| Fallopian Tubes | 4 | 2003 | 36 | 0.230 |
Why?
| Wound Healing | 2 | 2000 | 326 | 0.220 |
Why?
| Leuprolide | 5 | 1993 | 37 | 0.210 |
Why?
| Adult | 30 | 2006 | 24240 | 0.210 |
Why?
| Laparoscopy | 4 | 2003 | 655 | 0.210 |
Why?
| Decision Support Techniques | 1 | 2000 | 144 | 0.210 |
Why?
| Bandages | 1 | 1998 | 33 | 0.200 |
Why?
| Hyaluronic Acid | 1 | 1998 | 50 | 0.200 |
Why?
| Estrogens | 6 | 2007 | 179 | 0.200 |
Why?
| Fertilization | 2 | 1994 | 35 | 0.190 |
Why?
| Ovulation Detection | 1 | 1997 | 6 | 0.190 |
Why?
| Galactorrhea | 1 | 1997 | 6 | 0.180 |
Why?
| Coitus | 2 | 1994 | 14 | 0.180 |
Why?
| Hot Flashes | 2 | 2007 | 10 | 0.180 |
Why?
| Interleukin-1 | 2 | 1995 | 74 | 0.170 |
Why?
| Patient Selection | 1 | 2000 | 654 | 0.170 |
Why?
| Menstrual Cycle | 7 | 1991 | 55 | 0.170 |
Why?
| Receptors, Progesterone | 3 | 1991 | 165 | 0.160 |
Why?
| Fertility | 2 | 1997 | 89 | 0.160 |
Why?
| Pelvic Neoplasms | 2 | 1993 | 45 | 0.160 |
Why?
| Mice | 11 | 2002 | 10400 | 0.160 |
Why?
| Receptors, Estrogen | 3 | 1991 | 374 | 0.150 |
Why?
| Pregnancy, Animal | 1 | 1994 | 51 | 0.150 |
Why?
| Spermatozoa | 4 | 1987 | 67 | 0.150 |
Why?
| Peritoneal Neoplasms | 2 | 1988 | 175 | 0.150 |
Why?
| Tumor Necrosis Factor-alpha | 3 | 1995 | 663 | 0.150 |
Why?
| Nitric Oxide | 1 | 1995 | 261 | 0.140 |
Why?
| Embryo Transfer | 3 | 1987 | 33 | 0.140 |
Why?
| Hysteroscopy | 2 | 2003 | 4 | 0.130 |
Why?
| Membranes, Artificial | 1 | 1992 | 39 | 0.130 |
Why?
| Arteries | 2 | 2003 | 181 | 0.130 |
Why?
| Interferon-gamma | 2 | 2002 | 427 | 0.130 |
Why?
| Cautery | 1 | 1991 | 2 | 0.120 |
Why?
| Animals | 14 | 2002 | 25499 | 0.120 |
Why?
| Insemination, Artificial, Homologous | 2 | 1987 | 4 | 0.120 |
Why?
| Diethylstilbestrol | 2 | 1983 | 117 | 0.120 |
Why?
| Vagina | 2 | 1995 | 97 | 0.120 |
Why?
| Condylomata Acuminata | 1 | 1990 | 14 | 0.120 |
Why?
| Estradiol Congeners | 1 | 1990 | 9 | 0.110 |
Why?
| Ovarian Cysts | 1 | 1989 | 18 | 0.110 |
Why?
| Vaginal Neoplasms | 1 | 1990 | 78 | 0.110 |
Why?
| Menopause | 3 | 2007 | 60 | 0.110 |
Why?
| Oocytes | 2 | 1987 | 225 | 0.110 |
Why?
| Oxidation-Reduction | 3 | 1996 | 367 | 0.110 |
Why?
| Clomiphene | 3 | 1990 | 19 | 0.110 |
Why?
| Progestins | 2 | 2007 | 21 | 0.110 |
Why?
| Sperm-Ovum Interactions | 1 | 1989 | 1 | 0.110 |
Why?
| Pregnancy, Multiple | 1 | 1988 | 36 | 0.100 |
Why?
| Cervix Uteri | 1 | 1989 | 65 | 0.100 |
Why?
| Ovarian Neoplasms | 3 | 2003 | 611 | 0.100 |
Why?
| Aging | 2 | 1990 | 653 | 0.100 |
Why?
| Ovarian Diseases | 1 | 1987 | 32 | 0.090 |
Why?
| Vaginal Diseases | 1 | 2007 | 24 | 0.090 |
Why?
| Hysterosalpingography | 2 | 2003 | 8 | 0.090 |
Why?
| Prolactin | 2 | 1984 | 93 | 0.090 |
Why?
| Electrocoagulation | 2 | 1998 | 25 | 0.090 |
Why?
| Female Urogenital Diseases | 1 | 2006 | 9 | 0.090 |
Why?
| Acetaminophen | 1 | 1987 | 52 | 0.090 |
Why?
| Reproduction | 2 | 1994 | 182 | 0.080 |
Why?
| Male | 15 | 1997 | 39121 | 0.080 |
Why?
| Body Fluids | 1 | 1984 | 42 | 0.080 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1987 | 230 | 0.080 |
Why?
| Sperm Count | 2 | 1997 | 13 | 0.070 |
Why?
| Reoperation | 2 | 1997 | 565 | 0.070 |
Why?
| Drug Therapy, Combination | 4 | 1991 | 949 | 0.070 |
Why?
| Pregnancy Trimester, First | 1 | 2003 | 58 | 0.070 |
Why?
| Congenital Abnormalities | 1 | 2003 | 65 | 0.070 |
Why?
| Flow Cytometry | 2 | 1998 | 706 | 0.070 |
Why?
| Primary Ovarian Insufficiency | 1 | 2002 | 8 | 0.070 |
Why?
| Exudates and Transudates | 2 | 1993 | 13 | 0.070 |
Why?
| Retrospective Studies | 4 | 2003 | 6435 | 0.070 |
Why?
| Teratoma | 1 | 2003 | 43 | 0.070 |
Why?
| Sterilization Reversal | 1 | 1982 | 2 | 0.070 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 1983 | 132 | 0.070 |
Why?
| Mice, Inbred C3H | 2 | 1994 | 386 | 0.070 |
Why?
| Cell Count | 3 | 1991 | 210 | 0.070 |
Why?
| Mice, Inbred Strains | 2 | 1993 | 326 | 0.070 |
Why?
| Microspheres | 1 | 2002 | 166 | 0.060 |
Why?
| Disease Models, Animal | 2 | 2000 | 2124 | 0.060 |
Why?
| Intestinal Obstruction | 1 | 2003 | 104 | 0.060 |
Why?
| Blood Transfusion | 1 | 2003 | 138 | 0.060 |
Why?
| Nitric Oxide Synthase | 1 | 2002 | 124 | 0.060 |
Why?
| Treatment Outcome | 3 | 2007 | 7300 | 0.060 |
Why?
| Estrogen Receptor Modulators | 1 | 2000 | 9 | 0.060 |
Why?
| Biopsy | 1 | 2004 | 1108 | 0.060 |
Why?
| Endocrine Glands | 1 | 1980 | 14 | 0.060 |
Why?
| Risk Factors | 2 | 2007 | 4896 | 0.060 |
Why?
| Pregnancy Outcome | 2 | 1993 | 248 | 0.060 |
Why?
| Primary Prevention | 1 | 2000 | 77 | 0.060 |
Why?
| Needs Assessment | 1 | 2000 | 123 | 0.050 |
Why?
| Antineoplastic Agents | 1 | 1991 | 2280 | 0.050 |
Why?
| Microscopy, Electron | 1 | 2000 | 514 | 0.050 |
Why?
| Forecasting | 1 | 2000 | 297 | 0.050 |
Why?
| Abnormalities, Drug-Induced | 1 | 1979 | 20 | 0.050 |
Why?
| Anesthesia, General | 1 | 1980 | 123 | 0.050 |
Why?
| Reference Values | 3 | 2002 | 671 | 0.050 |
Why?
| Clinical Trials as Topic | 4 | 1996 | 1139 | 0.050 |
Why?
| Phagocytosis | 4 | 1987 | 79 | 0.050 |
Why?
| Regression Analysis | 2 | 1991 | 614 | 0.050 |
Why?
| Anesthesia, Intravenous | 1 | 1998 | 36 | 0.050 |
Why?
| Cryopreservation | 2 | 1990 | 71 | 0.050 |
Why?
| Surgical Procedures, Operative | 1 | 1980 | 171 | 0.050 |
Why?
| Polycystic Ovary Syndrome | 2 | 1990 | 199 | 0.050 |
Why?
| Follicle Stimulating Hormone | 3 | 1995 | 131 | 0.050 |
Why?
| Recurrence | 1 | 2000 | 1112 | 0.050 |
Why?
| Bromocriptine | 1 | 1997 | 12 | 0.050 |
Why?
| Time Factors | 3 | 1994 | 5245 | 0.050 |
Why?
| Hormone Antagonists | 1 | 1997 | 21 | 0.050 |
Why?
| Pelvic Inflammatory Disease | 2 | 1987 | 10 | 0.050 |
Why?
| Swine | 2 | 1990 | 534 | 0.040 |
Why?
| Disease Progression | 1 | 2000 | 1354 | 0.040 |
Why?
| Molsidomine | 1 | 1995 | 6 | 0.040 |
Why?
| Nitroprusside | 1 | 1995 | 40 | 0.040 |
Why?
| Middle Aged | 8 | 2006 | 23980 | 0.040 |
Why?
| Indomethacin | 1 | 1995 | 61 | 0.040 |
Why?
| Soybeans | 1 | 1995 | 12 | 0.040 |
Why?
| Cyclic GMP | 1 | 1995 | 59 | 0.040 |
Why?
| Uterine Hemorrhage | 2 | 1988 | 18 | 0.040 |
Why?
| Macrophage Activation | 2 | 2002 | 36 | 0.040 |
Why?
| Cells, Cultured | 5 | 2002 | 2867 | 0.040 |
Why?
| Hydrocortisone | 2 | 1995 | 297 | 0.040 |
Why?
| Hemoglobins | 1 | 1995 | 162 | 0.040 |
Why?
| Menstruation Disturbances | 2 | 1988 | 23 | 0.040 |
Why?
| Fallopian Tube Diseases | 2 | 1984 | 4 | 0.040 |
Why?
| Embryo Implantation | 1 | 1994 | 12 | 0.040 |
Why?
| Adnexa Uteri | 1 | 1994 | 11 | 0.040 |
Why?
| Abdominal Muscles | 1 | 1994 | 24 | 0.040 |
Why?
| Adenocarcinoma | 1 | 2003 | 1196 | 0.040 |
Why?
| Mice, Inbred ICR | 1 | 1994 | 64 | 0.040 |
Why?
| Adolescent | 3 | 1995 | 8442 | 0.040 |
Why?
| Epithelial Cells | 2 | 1995 | 589 | 0.040 |
Why?
| Body Temperature | 1 | 1994 | 113 | 0.040 |
Why?
| Hydrogen Peroxide | 2 | 1992 | 160 | 0.040 |
Why?
| Causality | 1 | 1993 | 70 | 0.040 |
Why?
| Leukocytes | 1 | 1994 | 183 | 0.030 |
Why?
| Osmolar Concentration | 1 | 1993 | 195 | 0.030 |
Why?
| Cell Communication | 1 | 1994 | 178 | 0.030 |
Why?
| Androgens | 2 | 1987 | 147 | 0.030 |
Why?
| Growth Substances | 1 | 1993 | 88 | 0.030 |
Why?
| Reactive Oxygen Species | 1 | 1995 | 437 | 0.030 |
Why?
| Antibodies | 2 | 1985 | 363 | 0.030 |
Why?
| Tomography, X-Ray Computed | 1 | 2003 | 2441 | 0.030 |
Why?
| Fibrosis | 1 | 1993 | 166 | 0.030 |
Why?
| Microscopy, Electron, Scanning | 1 | 1992 | 161 | 0.030 |
Why?
| Injections, Intramuscular | 1 | 1991 | 64 | 0.030 |
Why?
| Medroxyprogesterone Acetate | 1 | 1991 | 23 | 0.030 |
Why?
| HIV Antibodies | 1 | 1991 | 21 | 0.030 |
Why?
| Macrophage Colony-Stimulating Factor | 1 | 1991 | 19 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 1997 | 2046 | 0.030 |
Why?
| Gamete Intrafallopian Transfer | 1 | 1991 | 3 | 0.030 |
Why?
| Leukocyte Count | 2 | 1988 | 214 | 0.030 |
Why?
| Postmenopause | 2 | 2006 | 93 | 0.030 |
Why?
| Genetic Predisposition to Disease | 1 | 2000 | 2064 | 0.030 |
Why?
| Prospective Studies | 2 | 1997 | 3554 | 0.030 |
Why?
| Monocytes | 2 | 1991 | 317 | 0.030 |
Why?
| Stress, Psychological | 1 | 1994 | 281 | 0.030 |
Why?
| Luteal Phase | 1 | 1990 | 17 | 0.030 |
Why?
| Ovarian Follicle | 1 | 1990 | 55 | 0.030 |
Why?
| HIV-1 | 1 | 1991 | 154 | 0.030 |
Why?
| Teratogens | 1 | 1990 | 14 | 0.030 |
Why?
| Reproducibility of Results | 1 | 1997 | 2605 | 0.030 |
Why?
| Menstruation | 1 | 1990 | 30 | 0.030 |
Why?
| Contraceptives, Oral | 1 | 1990 | 43 | 0.030 |
Why?
| Metaplasia | 1 | 1990 | 42 | 0.030 |
Why?
| Mullerian Ducts | 1 | 1990 | 15 | 0.030 |
Why?
| Incidence | 1 | 1994 | 1503 | 0.030 |
Why?
| Papillomaviridae | 1 | 1990 | 108 | 0.030 |
Why?
| Cytokines | 1 | 1993 | 687 | 0.030 |
Why?
| Phagocytes | 1 | 1988 | 14 | 0.030 |
Why?
| Biological Assay | 1 | 1989 | 75 | 0.030 |
Why?
| alpha-Macroglobulins | 1 | 1988 | 3 | 0.030 |
Why?
| Anovulation | 2 | 1989 | 10 | 0.030 |
Why?
| Mucous Membrane | 1 | 1989 | 99 | 0.030 |
Why?
| Trypsin | 1 | 1988 | 98 | 0.030 |
Why?
| Neoplasms | 2 | 2001 | 2362 | 0.030 |
Why?
| Cattle | 1 | 1989 | 376 | 0.020 |
Why?
| Indium Radioisotopes | 1 | 1987 | 12 | 0.020 |
Why?
| Evaluation Studies as Topic | 1 | 1988 | 318 | 0.020 |
Why?
| Sperm Transport | 1 | 1987 | 1 | 0.020 |
Why?
| Cervix Mucus | 1 | 1987 | 4 | 0.020 |
Why?
| Professional Misconduct | 1 | 1987 | 21 | 0.020 |
Why?
| Muramidase | 1 | 1987 | 44 | 0.020 |
Why?
| Ovum | 1 | 1987 | 54 | 0.020 |
Why?
| Cell Separation | 1 | 1987 | 210 | 0.020 |
Why?
| Parity | 1 | 1987 | 90 | 0.020 |
Why?
| Immunohistochemistry | 1 | 1991 | 1773 | 0.020 |
Why?
| Steroids | 1 | 1987 | 154 | 0.020 |
Why?
| Peptides | 1 | 1990 | 613 | 0.020 |
Why?
| Pelvis | 1 | 1985 | 75 | 0.020 |
Why?
| Chemistry, Pharmaceutical | 1 | 2006 | 72 | 0.020 |
Why?
| Randomized Controlled Trials as Topic | 1 | 1989 | 783 | 0.020 |
Why?
| Inflammation | 1 | 1991 | 844 | 0.020 |
Why?
| Neoplasm Recurrence, Local | 1 | 1991 | 1082 | 0.020 |
Why?
| Prognosis | 1 | 1993 | 3424 | 0.020 |
Why?
| Ethics, Medical | 1 | 1987 | 301 | 0.020 |
Why?
| Administration, Oral | 1 | 2006 | 675 | 0.020 |
Why?
| Analysis of Variance | 1 | 1987 | 944 | 0.020 |
Why?
| Sex Factors | 1 | 1987 | 1044 | 0.020 |
Why?
| Pregnancy, Ectopic | 1 | 1983 | 36 | 0.020 |
Why?
| Cardiovascular Diseases | 1 | 1990 | 723 | 0.020 |
Why?
| Aged | 3 | 2006 | 17101 | 0.020 |
Why?
| Enzyme Induction | 1 | 2002 | 92 | 0.020 |
Why?
| Nitrites | 1 | 2002 | 26 | 0.020 |
Why?
| Nitrates | 1 | 2002 | 34 | 0.020 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2002 | 81 | 0.020 |
Why?
| Adenosarcoma | 1 | 2001 | 1 | 0.020 |
Why?
| Transplantation, Autologous | 1 | 1982 | 274 | 0.020 |
Why?
| Double-Blind Method | 1 | 2006 | 1819 | 0.020 |
Why?
| Infant, Newborn | 1 | 1987 | 2239 | 0.020 |
Why?
| Carcinoma, Endometrioid | 1 | 2001 | 33 | 0.010 |
Why?
| Cystadenocarcinoma, Serous | 1 | 2001 | 44 | 0.010 |
Why?
| Adenocarcinoma, Mucinous | 1 | 2001 | 46 | 0.010 |
Why?
| Interferon-alpha | 1 | 2002 | 234 | 0.010 |
Why?
| Adenocarcinoma, Clear Cell | 1 | 2001 | 55 | 0.010 |
Why?
| Lipopolysaccharides | 1 | 2002 | 260 | 0.010 |
Why?
| Severity of Illness Index | 1 | 2006 | 1647 | 0.010 |
Why?
| Neutrophils | 1 | 1981 | 254 | 0.010 |
Why?
| Danazol | 1 | 1978 | 2 | 0.010 |
Why?
| Pseudopregnancy | 1 | 1978 | 5 | 0.010 |
Why?
| Depression, Chemical | 1 | 1978 | 32 | 0.010 |
Why?
| Contraceptives, Oral, Synthetic | 1 | 1978 | 7 | 0.010 |
Why?
| Cell Movement | 1 | 1983 | 722 | 0.010 |
Why?
| Lymphocytes | 1 | 1981 | 460 | 0.010 |
Why?
| Pituitary Gland | 1 | 1978 | 102 | 0.010 |
Why?
| Complement System Proteins | 2 | 1991 | 83 | 0.010 |
Why?
| Random Allocation | 2 | 1990 | 356 | 0.010 |
Why?
| Cell Line | 1 | 2002 | 2551 | 0.010 |
Why?
| Synovial Membrane | 1 | 1995 | 27 | 0.010 |
Why?
| Sex Hormone-Binding Globulin | 1 | 1995 | 20 | 0.010 |
Why?
| Vimentin | 1 | 1995 | 45 | 0.010 |
Why?
| Isoflavones | 1 | 1995 | 14 | 0.010 |
Why?
| Keratins | 1 | 1995 | 73 | 0.010 |
Why?
| Coculture Techniques | 1 | 1995 | 149 | 0.010 |
Why?
| Agglutination Tests | 2 | 1985 | 11 | 0.010 |
Why?
| United States | 1 | 2006 | 5574 | 0.010 |
Why?
| Cell Division | 1 | 1995 | 755 | 0.010 |
Why?
| Immunoglobulin G | 2 | 1985 | 454 | 0.010 |
Why?
| Fibroblasts | 1 | 1995 | 703 | 0.010 |
Why?
| Diet | 1 | 1995 | 402 | 0.010 |
Why?
| RNA-Directed DNA Polymerase | 1 | 1991 | 17 | 0.010 |
Why?
| Antibodies, Monoclonal | 2 | 1989 | 1446 | 0.010 |
Why?
| Fluorescent Antibody Technique | 1 | 1991 | 334 | 0.010 |
Why?
| Genital Diseases, Female | 1 | 1990 | 24 | 0.010 |
Why?
| DDT | 1 | 1990 | 5 | 0.010 |
Why?
| Cytological Techniques | 1 | 1990 | 32 | 0.010 |
Why?
| Stimulation, Chemical | 1 | 1989 | 68 | 0.010 |
Why?
| Safety | 1 | 1990 | 163 | 0.010 |
Why?
| Blood Coagulation Factors | 1 | 1988 | 19 | 0.010 |
Why?
| Microscopy, Phase-Contrast | 1 | 1988 | 31 | 0.010 |
Why?
| Drug Evaluation | 1 | 1988 | 149 | 0.010 |
Why?
| Electrophoresis | 1 | 1988 | 58 | 0.010 |
Why?
| Histocytochemistry | 1 | 1988 | 133 | 0.010 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 1988 | 155 | 0.010 |
Why?
| Immunoenzyme Techniques | 1 | 1989 | 327 | 0.010 |
Why?
| Kinetics | 1 | 1991 | 1587 | 0.010 |
Why?
| Myometrium | 1 | 1988 | 41 | 0.010 |
Why?
| Endopeptidases | 1 | 1988 | 112 | 0.010 |
Why?
| Adnexal Diseases | 1 | 1987 | 11 | 0.010 |
Why?
| Staining and Labeling | 1 | 1988 | 180 | 0.010 |
Why?
| Dihydrotestosterone | 1 | 1987 | 27 | 0.010 |
Why?
| Androstenedione | 1 | 1987 | 31 | 0.010 |
Why?
| Gonadotropins | 1 | 1987 | 33 | 0.010 |
Why?
| Recombinant Proteins | 1 | 1988 | 1037 | 0.010 |
Why?
| Age Factors | 1 | 1990 | 1822 | 0.000 |
Why?
| Isotonic Solutions | 1 | 1984 | 21 | 0.000 |
Why?
| Sperm Agglutination | 1 | 1984 | 1 | 0.000 |
Why?
| Binding Sites, Antibody | 1 | 1984 | 57 | 0.000 |
Why?
| Postoperative Period | 1 | 1984 | 269 | 0.000 |
Why?
| Risk | 1 | 1984 | 675 | 0.000 |
Why?
| Clinical Competence | 1 | 1987 | 645 | 0.000 |
Why?
| Combined Modality Therapy | 1 | 1984 | 1608 | 0.000 |
Why?
| Breast Neoplasms | 1 | 1990 | 2567 | 0.000 |
Why?
|
|
Haney's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|